Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
American Journal of Infection Control|October 8, 2015
Poor hand hygiene by college students linked to more occurrences of infectious diseases, medical visits, and absence from classesKayla J Prater, Crystal A Fortuna, Janis L McGill, et al.
Bone Marrow Transplantation|July 23, 1998
T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cellsD Rondelli, C Anasetti, A Fortuna, et al.
Leukemia & Lymphoma|August 1, 1997
Interleukin-9 in human myeloid leukemia cellsR M Lemoli, A Fortuna, A Tafuri, et al.
Trends in Ecology & Evolution|May 29, 2018
Deciphering the Interdependence between Ecological and Evolutionary NetworksCarlos J Melián, Blake Matthews, Cecilia S de Andreazzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphomaR M Lemoli, G Rosti, G Visani, et al.
Acta Haematologica|January 1, 1996
Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patientsR M Lemoli, A Fortuna, M Fogli, et al.
British Journal of Haematology|May 12, 1998
Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrowM Fogli, M Amabile, G Martinelli, et al.
Leukemia & Lymphoma|March 1, 1994
Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cellsP L Zinzani, M Buzzi, P Farabegoli, et al.
Journal of Pharmaceutical Analysis|July 13, 2019
Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matricesA R Pinho, A Fortuna, A Falcão, et al.
Experimental Hematology|November 14, 1997
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studiesM R Motta, S Mangianti, S Rizzi, et al.
Pageof 18